ARG2 and chronic rhinosinusitis without nasal polyps: Our findings and those of other groups suggest that increased ARG2 activity reduces the synthesis of NO in the sinus mucosa of CRSsNP patients and stimulates type 1 (non-eosinophilic) inflammation [141].